Danaher to buy General Electric's bio pharma business Life Sciences for $21.4 billion
February 25, 2019 at 07:02 AM EST
Danaher will buy the bio-pharmaceutical business of General Electric in a $21.4 billion all cash deal, the companies announced on Monday.
